Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pizzo

Showing results (371-380 of 388) with videos related to

Pageof 39
Sort By:
Antimicrobial Agents and Chemotherapy|July 14, 1998
Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosingB U Mueller, B D Anderson, M Q Farley, et al.
The Journal of Infectious Diseases|March 1, 1990
From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained feverW T Hughes, D Armstrong, G P Bodey, et al.
American Journal of Ophthalmology|January 25, 1992
Retinal toxicity in human immunodeficiency virus-infected children treated with 2',3'-dideoxyinosineS M Whitcup, K M Butler, R Caruso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancerL M Krug, V A Miller, G P Kalemkerian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapyS N Bock, R E Lee, B Fisher, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected childrenB U Mueller, L L Lewis, G J Yuen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2002
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancerWalter T Hughes, Donald Armstrong, Gerald P Bodey, et al.
The American Journal of Medicine|August 1, 1979
Duration of empiric antibiotic therapy in granulocytopenic patients with cancerP A Pizzo, K J Robichaud, F A Gill, et al.
The Journal of Infectious Diseases|July 1, 1996
Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working GroupL L Lewis, D Venzon, J Church, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Prevention of acute emesis in cancer patients following high-dose cisplatin with the combination of oral dolasetron and dexamethasoneM G Kris, K B Pendergrass, R M Navari, et al.
Pageof 39

Showing results (371-380 of 388) with videos related to

Sort By:
Pageof 39
Antimicrobial Agents and Chemotherapy|July 14, 1998
Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosingB U Mueller, B D Anderson, M Q Farley, et al.
The Journal of Infectious Diseases|March 1, 1990
From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained feverW T Hughes, D Armstrong, G P Bodey, et al.
American Journal of Ophthalmology|January 25, 1992
Retinal toxicity in human immunodeficiency virus-infected children treated with 2',3'-dideoxyinosineS M Whitcup, K M Butler, R Caruso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancerL M Krug, V A Miller, G P Kalemkerian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapyS N Bock, R E Lee, B Fisher, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected childrenB U Mueller, L L Lewis, G J Yuen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2002
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancerWalter T Hughes, Donald Armstrong, Gerald P Bodey, et al.
The American Journal of Medicine|August 1, 1979
Duration of empiric antibiotic therapy in granulocytopenic patients with cancerP A Pizzo, K J Robichaud, F A Gill, et al.
The Journal of Infectious Diseases|July 1, 1996
Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working GroupL L Lewis, D Venzon, J Church, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Prevention of acute emesis in cancer patients following high-dose cisplatin with the combination of oral dolasetron and dexamethasoneM G Kris, K B Pendergrass, R M Navari, et al.
Pageof 39